Study Summary
This trial will test whether proton radiotherapy is effective in treating patients with liver cancer.
- Stage IA Hepatocellular Carcinoma
- Hepatocellular Carcinoma (HCC)
- Stage IIIB Hepatocellular Carcinoma
- Stage IIIA Hepatocellular Carcinoma
- Stage IB Hepatocellular Carcinoma
- Stage I Liver Cancer
- Stage III Liver Cancer
- Stage II Liver Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 10 Secondary · Reporting Duration: Up to 2 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Treatment (SBPT)
1 of 1
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: Proton Stereotactic Body Radiation Therapy · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What adverse effects have been seen in people who undergo Proton Stereotactic Body Radiation Therapy?
"We assessed the safety of Proton Stereotactic Body Radiation Therapy to be a 2 as this is still in Phase 2, thus there are some evidence-based findings that suggest its security but not efficacy." - Anonymous Online Contributor
What is the current projected sample size of this clinical trial?
"Yes, public records from clinicaltrials.gov demonstrate that this medical research initiative began recruiting patients on February 4th 2021 and has since been updated on May 11th 2022. The investigators aim to enroll 60 participants across two sites." - Anonymous Online Contributor
Is this medical trial still accepting participants?
"Per documentation found on clinicaltrials.gov, this medical research is still open for enrollment and was last modified in May of 2022; it had initially been posted to the site 6 months prior." - Anonymous Online Contributor